LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | PF431396 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3176 | 4156 | 0.7643 | 0.6646 |
MCF7 | PF477736 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2602 | 4156 | 0.6261 | 0.4680 |
MCF7 | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3573 | 4156 | 0.8599 | 0.8006 |
MCF7 | PHA-665752 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4485 | 4156 | 1.0791 | 1.1126 |
MCF7 | PHA-793887 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1311 | 4156 | 0.3155 | 0.0260 |
MCF7 | PI103 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3469 | 4156 | 0.8348 | 0.7650 |
MCF7 | PLX-4720 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4683 | 4156 | 1.1269 | 1.1806 |
MCF7 | QL-X-138 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1814 | 4156 | 0.4366 | 0.1983 |
MCF7 | QL-XII-47 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2788 | 4156 | 0.6710 | 0.5318 |
MCF7 | Radicicol | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2719 | 4156 | 0.6544 | 0.5082 |
MCF7 | Radicicol | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2568 | 4156 | 0.6179 | 0.4563 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4831 | 4156 | 1.1625 | 1.2313 |
MCF7 | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3891 | 4156 | 0.9363 | 0.9093 |
MCF7 | XL147 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4765 | 4156 | 1.1466 | 1.2086 |
MCF7 | Saracatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3767 | 4156 | 0.9064 | 0.8669 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3986 | 4156 | 0.9592 | 0.9420 |
MCF7 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2655 | 4156 | 0.6390 | 0.4863 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3940 | 4156 | 0.9482 | 0.9262 |
MCF7 | SU11274 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4880 | 4156 | 1.1743 | 1.2481 |
MCF7 | Fedratinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4587 | 4156 | 1.1037 | 1.1475 |
MCF7 | TGX221 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3428 | 4156 | 0.8248 | 0.7507 |
MCF7 | Torin1 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1714 | 4156 | 0.4126 | 0.1641 |
MCF7 | Torin2 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1225 | 4156 | 0.2947 | -0.0036 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1440 | 4156 | 0.3465 | 0.0701 |
MCF7 | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2062 | 4156 | 0.4961 | 0.2830 |